Preclinical trials serve as a critical stepping stone in the journey from laboratory discovery to human application, especially in the realm of non-conventional cancer therapies. This article examines the significance of preclinical trials in the therapeutic development of promising drugs like Ivermectin and Mebendazole. By highlighting their current research landscape, we emphasize the undeniable importance of this phase in paving the way for groundbreaking cancer treatments.
Courage Against Cancer 